TumorDiagnostik & Therapie 2017; 38(05): 323-329
DOI: 10.1055/s-0043-103975
Thieme Onkologie aktuell
© Georg Thieme Verlag KG Stuttgart · New York

Aktueller Stand Salvage-chirurgischer Therapiekonzepte bei Rezidivtumoren des Larynx und Pharynx

The current role of salvage-surgery of recurrent tumors in the larynx and pharynx
B. A. Stuck
1   Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, Universitätsklinikum Essen, Universität Duisburg-Essen
,
N. Rothmeier
2   HNO-Gemeinschaftspraxis, Gelsenkirchen
,
S. Mattheis
1   Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, Universitätsklinikum Essen, Universität Duisburg-Essen
,
N. Dominas
1   Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, Universitätsklinikum Essen, Universität Duisburg-Essen
,
S. Lang
1   Klinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, Universitätsklinikum Essen, Universität Duisburg-Essen
› Author Affiliations
Further Information

Publication History

Publication Date:
08 June 2017 (online)

Zusammenfassung

Die therapeutischen Konzepte bei Kopf-Hals-Malignomen haben in den letzten 20 Jahren einen erheblichen Wandel erfahren, der mit einer zunehmenden Bedeutung nicht-chirurgischer Therapieverfahren einhergeht. Auch unter den Organerhaltungsprotokollen bzw. nach primärer Radiochemotherapie kommt es jedoch in erheblichem Umfang zum Auftreten von Tumorrezidiven. In dieser Situation stellt die Salvage- bzw. Rettungschirurgie im Kopf-Hals-Bereich häufig die einzig noch verbliebene kurative Option dar. Die Etablierung plastisch-rekonstruktiver Maßnahmen vor ca. 30 Jahren hat das operative Spektrum im Kopf-Hals-Bereich signifikant erweitert und neue Möglichkeiten der Salvage-Chirurgie bei rezidivierenden Karzinomen des Pharynx und Larynx eröffnet. Die Überlebensraten nach Salvage-Chirurgie hängen hierbei im Wesentlichen von der Art der Primärtherapie, der Lokalisation und dem Tumorstadium sowohl bei Erstdiagnose als auch zum Zeitpunkt des Rezidivs ab. Zur plastisch-rekonstruktiven Deckung kommen gestielte Lappen oder mikrovaskulär-anastomosierte Transplantate zum Einsatz. Die am häufigsten angewandten gestielten Lappen sind der M. pectoralis-major- und der Latissimus-dorsi-Lappen. Als freie Transplantate kommt meist das Radialis- oder ALT-Transplantat zum Einsatz. Durch Verwendung dieser Lappen und Transplantate wird nicht-bestrahltes Gewebe in die vorgeschädigten Regionen verlagert, um neben der Wiederherstellung der ursprünglichen Organfunktion auch gefürchtete postoperative Komplikationen, wie z. B. Speichelfisteln, zu reduzieren. Die Indikation zur Salvage-Chirurgie muss auch weiterhin in jedem Einzelfall vor dem Hintergrund der zu erwartenden Morbidität und einer realistischen Einschätzung der Erfolgsaussichten abgewogen werden. Die vorliegende Publikation möchte hierzu entsprechende Empfehlungen geben.

Abstract

Over the past 20 years, the therapeutic concepts for the treatment of head and neck cancer have evolved and non-surgical treatment strategies have gained in importance. However, despite improved organ preservation protocols and primary chemoradiation, tumor recurrence is still frequent. Under these conditions, salvage surgery if often the only remaining curative treatment option. Over the past 30 years, advancements in plastic-reconstructive surgery have broadened the surgical spectrum in the head and neck area, offering new treatment options for salvage surgery in recurrent cancer of the pharynx and larynx. Survival after salvage surgery mainly depends on the primary treatment modality as well as the localization and tumor stage at the time of initial diagnosis and local recurrence. For the reconstruction of defects after salvage surgery, pedicled flaps and microvascular free flaps may be utilized. The most frequently used flaps in these situations are the pectoralis major island- or the myocutaneous latissimus dorsi island flap. The radial forearm and the ALT-flap are potentially applicable free flaps. With the use of these flaps, vital tissue is transferred into the previously irradiated area, hereby allowing for reconstruction and functional preservation of the resected area and preventing complications such as fistulas. The expected morbidity and the likelihood of surgical success must be assessed thoroughly in every individual case prior to performing salvage surgery. This review aims to support decision making in these situations.

 
  • Literatur

  • 1 Lefebvre JL, Chevalier D, Luboinski B. et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996; 88: 890-899
  • 2 The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1690
  • 3 Chen AY, Schrag N, Yongping H. et al. Changes in treatment of advanced laryngeal cancer 1985-2001. Otolaryngol Head Neck Surg 2006; 135: 831-837
  • 4 Hoffman HT, Porter K, Karnell LH. et al. Laryngeal cancer in the United States: Changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 16-21
  • 5 Hörmann K, Sadick H. Role of surgery in the management of head and neck cancer: a contemporary view of the data in the era of organ preservation. J Laryngol Otol 2013; 127: 121-127
  • 6 Grover S, Swisher-McClure S, Mitra N. et al. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes. Int J Radiat Oncol Biol Phys 2015; 92: 594-601
  • 7 Rosenthal DI, Mohamed AS, Weber RS. et al. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey. Int J Radiat Oncol Biol Phys 2015; 92: 594-601
  • 8 Bücheler BM, Ehnes A, Kavsadze M. et al. Lebensqualität nach Therapie von Kopf-Hals-Tumoren. Longitudinaler Vergleich von Operation und adjuvanter Radio(chemo)therapie. HNO 2012; 60: 1053-1059
  • 9 Tschiesner U, Schuster L, Strieth S. et al. Functional outcome in patients with advanced head and neck cancer: surgery and reconstruction with free flaps versus primary radiochemotherapy. Eur Arch Otorhinolaryngol 2012; 269: 629-638
  • 10 Hanna E, Sherman A, Cash D. et al. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 2004; 130: 875-879
  • 11 Machtay M, Moughan J, Trotti A. et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589
  • 12 Chen AY, Schrag N, Yongping H. et al. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope 2007; 117: 16-21
  • 13 Lee SC, Shores CG, Weissler MC. Salvage surgery after failed primary concomitant chemoradiation. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 135-140
  • 14 Stoeckli SJ, Pawlik AB, Lipp M. et al. Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg 2000; 126: 1473-1477
  • 15 Taki S, Homma A, Oridate N. et al. Salvage surgery for local recurrence after chemoradiotherapy or radiotherapy in hypopharyngeal cancer patients. Eur Arch Otorhinolaryngol 2010; 267: 1765-1769
  • 16 Agra IM, Carvalho AL, Ulbrich FS. et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 2006; 28: 107-113
  • 17 Röösli C, Studer G, Stoeckli SJ. Salvage treatment for recurrent oropharyngeal squamous cell carcinoma. Head Neck 2010; 32: 989-996
  • 18 Gilbert H, Kagan AR. Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx. J Surg Oncol 1974; 6: 357-380
  • 19 Rothmeier N, Bergmann C, Mattheis S. et al. The primary use of pectoralis myofascial flap in salvage laryngectomy. Laryngorhinootologie 2015; 94: 232-238
  • 20 Goodwin Jr WJ. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?. Laryngoscope 2000; 110: 1-18
  • 21 Matoscevic K, Graf N, Pezier TF. et al. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC. Otolaryngol Head Neck Surg 2014; 151: 454-461
  • 22 Gleich LL, Ryzenman J, Gluckman JL. et al. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible?. Arch Otolaryngol Head Neck Surg 2004; 130: 35-38
  • 23 Grant DG, Salassa JR, Hinni ML. et al. Transoral laser microsurgery for recurrent laryngeal and pharyngeal cancer. Otolaryngol Head Neck Surg 2008; 138: 606-613
  • 24 Marioni G, Marchese-Ragona R, Pastore A. et al. The role of supracricoid laryngectomy for glottic carcinoma recurrence after radiotherapy failure: a critical review. Acta Otolaryngol 2006; 126: 1245-1251
  • 25 Steiner W, Vogt P, Ambrosch P. et al. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy. Head Neck 2004; 26: 477-484
  • 26 Yiotakis J, Stavroulaki P, Nikolopoulos T. et al. Partial laryngectomy after irradiation failure. Otolaryngol Head Neck Surg 2003; 128: 200-209
  • 27 Yasumatsu R, Nakashima T, Toh S. et al. Salvage of recurrent hypoharyngeal carcinoma after primary curative treatment. Acta Oto-Laryngologica 2013; 133: 1110-1116
  • 28 Clark JR, de Almeida J, Gilbert R. et al. Primary and salvage (hypo)pharyngectomy: analysis and outcome. Head Neck 2006; 28: 671-677
  • 29 Dubsky PC, Stift A, Rath T. et al. Salvage surgery for recurrent carcinoma of the hypopharynx and reconstruction using jejunal free tissue transfer and pectoralis major muscle pedicled flap. Arch Otolaryngol Head Neck Surg 2007; 133: 551-555
  • 30 Zafereo ME, Hanasono MM, Rosenthal DI. et al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer 2009; 115: 5723-5733
  • 31 Klozar J, Cada Z, Koslabova E. Complications of total laryngectomy in the era of chemoradiation. Eur Arch Otorhinolaryngol 2012; 269: 289-293
  • 32 Dirven R, Swinson BD, Gao K. et al. The assessment of pharyngocutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypopharynx. Laryngoscope 2009; 119: 1691-1695
  • 33 Basheeth N, O´Leary G, Sheaban P. Pharyngocutaneous fistula after salvage laryngectomy: Impact of interval between radiotherapy and surgery, and performance of bilateral neck dissection. Head Neck 2014; 36: 580-584
  • 34 Tsou YA, Hua CH, Lin MH. et al. Comparison of pharyngocutaneous fistula between patients followed by primary laryngopharygnectomy and salvage laryngopharyngectomy for advanced hypoharyngeal cancer. Head Neck 2010; 32: 1494-1500
  • 35 Rothmeier N, Hoffmann TK, Lehnerdt G. et al. Surgical management of persisting fistulas after salvage-laryngectomy. Laryngo-Rhino-Otol 2013; 92: 236-243
  • 36 Patel UA, Keni SP. Pectoralis myofascial flap during salvage laryngectomy prevents pharyngocutaneous fistula. Otolaryngol Head Neck Surg 2009; 141: 190-195
  • 37 Gil Z, Gupta A, Kummer B. et al. The role of pectoralis major muscle flap in salvage total laryngectomy. Arch Otolaryngol Head Neck Surg 2009; 135: 1019-1023
  • 38 Patel UA, Moore BA, Wax M. et al. Impact of pharyngeal closure technique on fistula after salvage laryngectomy. Otolaryngol Head Neck Surg 2013; 139: 1156-1162
  • 39 Lian TS, Nathan CA. What is the role of flap reconstruction in salvage total laryngectomy?. Laryngoscope 2014; 124: 2441-2442
  • 40 Kostrzewa JP, Lancaster WP, Iseli TA. et al. Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. Laryngoscope 2010; 120: 267-272
  • 41 Ishigami T, Uzawa K, Higo M. et al. Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer 2007; 120: 2262-2270
  • 42 Ogawa K, Murayama S, Mori M. Predicting the tumor response to radiotherapy using microarray analysis (Review). Oncol Rep 2007; 18: 1243-1248